Literature DB >> 20389244

Recent developments in pediatric headache.

Andrew D Hershey1.   

Abstract

PURPOSE OF REVIEW: This review will focus on some of the recent findings in pediatric headache including headache characteristics, epidemiology, comorbid associations and treatment updates. RECENT
FINDINGS: Pediatric headache remains a frequent health problem for children and their families, yet there remain many gaps in our knowledge. This review will broadly address some of the recent findings and highlight the gaps in our understanding and treatment of pediatric headache. There will be a focus on pediatric migraine as this has been the best characterized and studied.
SUMMARY: Our understanding of pediatric headache is improving with increased recognition of the characteristics and associated symptomology. This should further guide the individualized treatment approaches for improved outcome and reduction of progression into adulthood.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20389244     DOI: 10.1097/WCO.0b013e3283391888

Source DB:  PubMed          Journal:  Curr Opin Neurol        ISSN: 1350-7540            Impact factor:   5.710


  3 in total

1.  Altered cortical activation in adolescents with acute migraine: a magnetoencephalography study.

Authors:  Jing Xiang; Xinyao deGrauw; Milena Korostenskaja; Abraham M Korman; Hope L O'Brien; Marielle A Kabbouche; Scott W Powers; Andrew D Hershey
Journal:  J Pain       Date:  2013-06-21       Impact factor: 5.820

2.  The clinical characteristics of primary headache and associated factors in children: A retrospective descriptive study.

Authors:  Miral Al Momani; Basima A Almomani; Amira T Masri
Journal:  Ann Med Surg (Lond)       Date:  2021-05-02

3.  Neuromagnetic abnormality of motor cortical activation and phases of headache attacks in childhood migraine.

Authors:  Jing Xiang; Xinyao Degrauw; Abraham M Korman; Janelle R Allen; Hope L O'Brien; Marielle A Kabbouche; Scott W Powers; Andrew D Hershey
Journal:  PLoS One       Date:  2013-12-27       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.